Clinical efficacy of anti-Mullerian hormone inspection in supporting diagnosis for climacteric disorders


The diagnosis of climacteric disorders in gynecology is performed on the basis of symptoms rather than hormonal levels. Generally, the follicle-stimulating hormone (FSH) level increases when the 17β-estradiol (E2) level decreases in menopause. However, the problem of these hormones should be determined by strict timing of sampling, and there are individual specificities of decreases of hormone levels. We considered that anti-Mullerian hormone (AMH) can be measured at any time of the menstrual cycle and that it shows ovary functional decline earlier than FSH/E2, and we examined whether AMH would possibly become a good index for climacteric disorders. The subjects were 163 healthy females and 21 patients with climacteric disorders between 20 and 59 years old. We examined AMH, FSH and E2 at the same time. It is understood that in healthy females, AMH decreases with age and a decline in ovary function occurs at a relatively early age. Patients visiting clinics for climacteric disorders often have normal-range serum FSH/E2 levels, and it is clear that these values could not serve as indices of menopause at these inspections. Upon measurement of AMH in patients with climacteric disorders, most showed less than normal range (< 14 pmol/L), suggesting a decline in ovarian function. In addition, AMH was low in females with climacteric disorders compared with those without them. In conclusion, AMH was suggested as an objective index for climacteric disorders and possibly as a new diagnostic marker.

Share and Cite:

Namiki, T. , Kakikura, H. , Matsumoto, Y. , Koichi, U. , Sato, H. , Chino, A. , Hisanaga, A. , Kaneko, A. , Kita, T. , Kihara, M. , Shozu, M. and Terasawa, K. (2011) Clinical efficacy of anti-Mullerian hormone inspection in supporting diagnosis for climacteric disorders. Open Journal of Internal Medicine, 1, 93-98. doi: 10.4236/ojim.2011.13018.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Speroff, L. and Fritz, M. (2005) The clinical gynecologic endocrinology and infertility. 7th Edition, Lippincott Williams & Wilkins, Philadelphia.
[2] Japan Society of Obstetrics and Gynecology & Japan Menopause Society (2009) Guideline for Hormone Replacement Therapy 2009 (in Japanese). Tokyo.
[3] Cate, R.L., Mattaliano, R.J., Hession, C., Tizard, R., Farber, N.M., Cheung, A., Ninfa, E.G., Frey, A.Z., Gash D.J. and Chow, E.P. (1986) Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cells. Cell, 45, 685-698. doi:10.1016/0092-8674(86)90783-X
[4] Cohen-Haguenauer, O., Picard, J.Y., Matti, M.G., Serero, S., Nguyen, V.C., de Tand, M.F., Guerrier, D., Hors-Cayla, M.C., Josso, N. and Frzal, J. (1987) Mapping of the gene for anti-müllerian hormone to the short arm of human chromosome 19. Cytogenetics and Cell Genetics, 44, 2-6. doi:10.1159/000132332
[5] Vigier, B., Picard, J.Y., Tran, D., Legeai, L. and Josso, N. (1984) Another homology between sertoli and granulosa cells. Endocrinology, 114, 1315-1320. doi:10.1210/endo-114-4-1315
[6] Teixeira, J., Maheswaran, S. and Donahoe, P.K. (2001) Müllerian inhibiting substance: An instructive developmental hormone with diagnostic and possible therapeutic applications. Endocrine Reviews, 22, 657-674. doi:10.1210/er.22.5.657
[7] De Vet, A., Laven, J.S.E., de Jong, F., Legeai, L. and Josso, N. (2002) Antimüllerian hormone serum levels: A putative marker for ovarian aging. Fertility and Sterility, 77, 357-362. doi:10.1016/S0015-0282(01)02993-4
[8] Hale, G., Zhao, X., Hughes, C., Burger, H., Robertson, D. and Fraser, I. (2007) Endocrine features of menstrual cycles in middle and late reproductive age and the menopausal transition classified according to the staging of reproductive aging workshop (STRAW) staging system. Journal of Clinical Endocrinology and Metabolism, 92, 3060-3067. doi:10.1210/jc.2007-0066
[9] Tehrani, F., Solaymani-Dodaran, M. and Azizi, F. (2009) A single test of antimullerian hormone in late reproductive-aged female is a good predictor of menopause. Menopause, 16, 797-802. doi:10.1097/GME.0b013e318193e95d
[10] La Marca, A., Stabile, G., Artenisio, A.C. and Volpe, A. (2006) Serum anti-mullerian hormone throughout the human menstrual cycle. Human Repoduction, 21, 3103- 3107. doi:10.1093/humrep/del291
[11] Sowers, M., McConnell, D., Gast, K., Zheng, H., Nan, B., McCarthy, J.D. and Randolph J.F. (2010) Anti-mullerian hormone and inhibin B variability during normal menstrual cycles. Fertility and Sterility, 94, 1432-1486. doi:10.1016/j.fertnstert.2009.07.1674
[12] Iwase, A. and Ishizuka, B. (2009) Evaluation of ovarian reserve function. (in Japanese). Acta Obstetrica et Gynaecologica Japonica, 61, 330-334.
[13] Sowers, M., Eyvazzadeh, A., McConnell, D., Yosef, M., Jannausch, M., Zhang, D., Harlow, S. and Randolph, J. (2008) Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. Journal of Clinical Endocrinology and Metabolism, 93, 3478-3483. doi:10.1210/jc.2008-0567
[14] La Marca, A., Sighinolfi, G., Radi, D., Argento, C., Baraldi, E., Artenisio, A.C., Stabile, G. and Volpe, A. (2010) Anti-mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Human Reproduction Update, 16, 113-130.
[15] Knight, P. and Glister, C. (2006) TGF-beta superfamily members and ovarian follicle development. Reproduction, 132, 191-206. doi:10.1530/rep.1.01074
[16] Andersen, C., Rosendahl, M. and Byskov, A. (2008) Concentration of anti-müllerian hormone and inhibin-B in relation to steroids and age in follicular fluid from small antral human follicles. Journal of Clinical Endocrinology and Metabolism, 93, 2344-2349. doi:10.1210/jc.2007-2342
[17] Welt, C.K., Martin, K.A., Taylor, A.E., Lambert-Messerlian, G.M., Crowley, W.F., Smith, J.A., Schoenfeld, D.A. and Hall, J.E. (1997) Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: Evidence for FSH control of inhibin B in normal women. Journal of Clinical Endocrinology and Metabolism, 82, 2645-2652.doi:10.1210/jc.82.8.2645
[18] Durlinger, A.L., Kramer, P., Karels, B., de Jong, F.H., Uilenbroek, J.T., Grootegoed, J.A. and Themmen, A.P. (1999) Control of primordial follicle recruitment by anti-müllerian hormone in the mouse ovary. Endocrinology, 140, 5789-5796. doi:10.1210/en.140.12.5789

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.